Novo Nordisk Investigational Site

Cologne 50924

0 studies enrolling now · 2 studies all time

What they study most

Acquired Bleeding Disorder, Bleeding During/Following Surgery, Cardiac Surgery Requiring Cardiopulmonary Bypass

Studies at this site

• Use of Activated Recombinant Human Factor VII in Cardiac Surgery — Stopped early
• Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation — Completed